Displaying 126 - 130 of 223
Wed 04 November 2015
We are outraged that as of today, (Wednesday 4th November), the life-extending drug Abraxane is no longer available to newly eligible patients with advanced pancreatic cancer in England through the Cancer Drugs Fund (CDF).Read More about 'Life extending drug no longer available to new patients with advanced pancreatic cancer in England'
Sun 01 November 2015
On the first day of Pancreatic Cancer Awareness Month, Pancreatic Cancer UK announces it will fund over £1 million of ground breaking research into treatments for pancreatic cancer which could mean a longer life for thousands of people.Read More about 'Over £1 million invested in research into treatments for pancreatic cancer'
Fri 30 October 2015
New research into the development of a potential new immunotherapy treatment for pancreatic cancer has been reported today in the media.Read More about 'Hopes for new immunotherapy treatment'
Thu 17 September 2015
The National Institute for Health and Care Excellence (NICE) has today (Thursday, 17th September) announced it will not allow advanced pancreatic cancer patients in England routine access to the life-extending drug Abraxane on the NHS.Read More about 'Last hope dashed for access to life-extending pancreatic cancer drug on the NHS in England'
Fri 11 September 2015
Research findings into the use of an anti-diabetic drug that can be used to ‘suffocate’ pancreatic cancer stem cells have been widely reported in the media today. Here's our comment.Read More about 'Anti-diabetic drug to 'suffocate' pancreatic cancer cells is promising'